DexCom Inc/ US2521311074 /
28/08/2024 22:00:00 | Chg. -1.7600 | Volume | Bid01:12:23 | Ask01:12:23 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
70.4800USD | -2.44% | 4.09 mill. Turnover: 217.13 mill. |
70.3100Bid Size: 100 | 70.4000Ask Size: 900 | 28.24 bill.USD | - | 50.34 |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 1.40 USD | 59.09% |
EPS Diluted: | 1.30 USD | 58.54% |
Revenues per Share: | 9.40 USD | 24.78% |
Book Value per Share: | 5.37 USD | -2.74% |
Cash Flow per Share: | 1.94 USD | 12.06% |
Dividend per Share: | - USD | - |
Total | in mill. | |
Revenues: | 3,622.30 USD | 24.49% |
Net Income: | 541.50 USD | 58.70% |
Operating Cash Flow: | 748.50 USD | - |
Cash and Cash Equivalents: | 566.30 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 50.34 | 88.64 |
P/S Ratio: | 7.50 | 13.21 |
P/BV ratio: | 13.14 | 23.13 |
P/CF Ratio: | 36.30 | 63.91 |
PEG: | 0.85 | 1.50 |
Earnings Yield: | 1.99% | 1.13% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 28.24 bill. USD | 47.84 bill. USD |
Free Float Market Cap.: | - USD | - USD |
Market Cap. / Employee: | - USD | - USD |
Shares Outstanding: | 400.73 mill. |
Profitability
Gross Profit Margin: | 63.19% |
EBIT Margin: | 16.50% |
Net Profit Margin: | 14.95% |
Return on Equity: | 26.18% |
Return on Assets: | 8.64% |
Financial Strength
Liquidity I / Cash Ratio: | 0.36% |
Liquidity II / Quick Ratio: | 0.99% |
Liquidity III / Current Ratio: | 2.84% |
Debt / Equity Ratio: | 1.18% |
Dynam. Debt / Equity Ratio: | 560.57% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 31/12/2023 |
Accounting Standard: | US GAAP |
Currency: | USD |